(F-18) fluorodeoxyglucose positron emission tomography as a predictor of pathologic grade and other prognostic variables in bone and soft tissue sarcoma

Clinical Cancer Research

Volumn 6, Issue 4, 2000, Pages 1279-1287

  Folpe, Andrew L ^a,c   Lyles, Robert H ^a   Sprouse, Jason T ^b   Conrad III, E U ^b   Eary, Janet F ^b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

^c EMORY UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; BONE BIOPSY; BONE TUMOR; CANCER GRADING; CELL CYCLE S PHASE; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; OSTEOSARCOMA; POSITRON EMISSION TOMOGRAPHY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; SOFT TISSUE SARCOMA;

ADULT; AGED; BONE NEOPLASMS; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; DATA INTERPRETATION, STATISTICAL; FLUORODEOXYGLUCOSE F18; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MIDDLE AGED; NEOPLASM STAGING; NUCLEAR PROTEINS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MDM2; SARCOMA; SOFT TISSUE NEOPLASMS; TOMOGRAPHY, EMISSION-COMPUTED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0034049414     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Kole, A. C., Nieweg, O. E., van Ginkel, R. J., Pruim, J., Hoekstra, H. J., Paans, A. M., Vaalburg, W. and Koops, H. S. Detection of local recurrence of soft-tissue sarcoma with positron emission tomography using [18F]fluorodeoxyglucose. Ann. Surg. Oncol., 4: 57-63, 1997.
2. Miraldi, F., Adler, L. P., and Faulhaber, P. PET imaging in soft tissue sarcomas. Cancer Treat. Res., 91: 51-64, 1997.
3. Jones, D. N., McCowage, G. B., Sostman, H. D., Brizel, D. M., Layfield, L. Charles, H. C., Dewhirst, M. W., Prescott, D. M., Friedman, H. S., Harrelson, J. M., Scully, S. P., and Coleman, R. E. Monitoring of neoadjuvant therapy response of soft-tissue and musculoskeletal sarcoma using fluorine-18-FDG PET. J. Nucl. Med., 37: 1438-1444, 1996.
4. Nieweg, O. E., Pruim, J. Hoekstra, H. J., Paans, A. M., Vaalburg, W. Oldhoff, J. and Schraffordt Koops, H. Positron emission tomography with fluorine-18-fluorodeoxyglucose for the evaluation of therapeutic isolated regional limb perfusion in a patient with soft-tissue sarcoma. J. Nucl. Med., 35: 90-92, 1994.
5. Adler, L. P., Blair, H. F., Makley, J. T., Williams, R. P., Joyce, M. J., Leisure, G., al-Kaisi, N., and Miraldi, F. Noninvasive grading of musculoskeletal tumors using PET. J. Nucl. Med., 32: 1508-1512, 1991.
6. Adler, L. P., Blair, H. F., Williams, R. P., Pathria, M. N., Makley, J. T., Joyce, M. J., al-Kaisi, N., and Miraldi, F. Grading liposarcomas with PET using [18F]FDG. J. Comput. Assisted Tomogr., 14: 960-962, 1990.
7. Griffeth, L. K., Dehdashti, F., McGuire, A. H., McGuire, D. J., Perry, D. J., Moerlein, S. M., and Siegel, B. A. PET evaluation of soft-tissue masses with fluorine-18 fluoro-2-deoxy-D-glucose. Radiology, 182: 185-194, 1992.
8. Kern, K. A., Brunetti, A., Norton, J. A., Chang, A. E., Malawer, M. Lack, E., Finn, R. D., Rosenberg, S. A., and Larson, S. M. Metabolic imaging of human extremity musculoskeletal tumors by PET. J. Nucl. Med., 29: 181-186, 1988.
9. Lodge, M. A., Lucas, J. D., Marsden, P. K., Cronin, B. F., O'Doherty, M. J., and Smith, M. A. A PET study of 18FDG uptake in soft tissue masses. Eur. J. Nucl. Med., 26: 22-30, 1999.
10. Kole, A. C., Nieweg, O. E., Hoekstra, H. J., van Horn, J. R., Koops, H. S., and Vaalburg, W. Fluorine-18-fluorodeoxyglucose assessment of glucose metabolism in bone tumors. J. Nucl. Med., 39: 810-815, 1998.
11. Eary, J. F., Conrad, E. U., Bruckner, J. D., Folpe, A., Hunt, K. J., Mankoff, D. A., and Howlett, A. T. Quantitative [F-18]fluorodeoxyglucose positron emission tomography in pretreatment and grading of sarcoma. Clin. Cancer Res., 4: 1215-1220, 1998.
12. Guillou, L., Coindre, J. M., Bonichon, F., Nguyen, B. B., Terrier, P., Collin, F., Vilain, M. O., Mandard, A. M., Le Doussal, V., Leroux, A., Jacquemier, J., Duplay, H., Sastre-Garau, X. and Costa, J. Comparative study of the National Cancer Institute and French Federation of Cancer Centers Sarcoma Group grading systems in a population of 410 adult patients with soft tissue sarcoma. J. Clin. Oncol., 15: 350-362, 1997.
13. Meis-Kindblom, J. M., Bergh, P., Gunterberg, B., and Kindblom, L. G. Extraskeletal myxoid chondrosarcoma: a reappraisal of its morphologic spectrum and prognostic factors based on 117 cases. Am. J. Surg. Pathol., 23: 636-650, 1999.
14. Heslin, M. J., Cordon-Cardo, C., Lewis, J. J., Woodruff, J. M., and Brennan, M. F. Ki-67 detected by MIB-1 predicts distant metastasis and tumor mortality in primary, high grade extremity soft tissue sarcoma. Cancer (Phila.), 83: 490-497, 1998.
15. Eary, J. F., and Mankoff, D. A. Tumor metabolic rates in sarcoma using FDG PET. J. Nucl. Med., 39: 250-254, 1998.
16. Drobnjak, M., Latres, E., Pollack, D., Karpeh, M., Dudas, M., Woodruff, J. M., Brennan, M. F., and Cordon-Cardo, C. Prognostic implications of p53 nuclear overexpression and high proliferation index of Ki-67 in adult soft-tissue sarcomas. J. Natl. Cancer Inst., 86: 549-554, 1994.
17. Bodensteiner, D., Reidinger, D., Rosenfeld, C., Neff, J., and Lin, F. Flow cytometry of needle aspirates from bone and soft tissue tumors. South. Med. J., 84: 1451-1454, 1991.
18. Costa, J., Wesley, R. A., Glatstein, E., and Rosenberg, S. A. The grading of soft tissue sarcomas. Results of a clinicohistopathologic correlation in a series of 163 cases. Cancer (Phila.), 53: 530-541, 1984.
19. Bauer, H. C., Kreicbergs, A., and Tribukait, B. DNA content prognostic in soft tissue sarcoma. 102 patients followed for 1-10 years. Acta Orthop. Scand., 62: 187-194, 1991.
20. Conover, W. J. Practical Nonparametric Statistics. New York: Wiley, 1999.
21. Alvegard, T. A., Berg, N. O., Baldetorp, B., Ferno, M., Killander, D., Ranstam, J., Rydholm, A., and Akerman, M. Cellular DNA content and prognosis of high-grade soft tissue sarcoma: the Scandinavian Sarcoma Group experience. J. Clin. Oncol., 8: 538-547, 1990.
22. Choong, P. F., Akerman, M., Willen, H., Andersson, C., Gustafson, P., Baldetorp, B., Ferno, M., Alvegard, T., and Rydholm, A. Prognostic value of Ki-67 expression in 182 soft tissue sarcomas. Proliferation - a marker of metastasis? Apmis, 102: 915-924, 1994.
23. Agarwal, V., Greenebaum, E., Wersto, R., and Koss, L. G. DNA ploidy of spindle cell soft-tissue tumors and its relationship to histology and clinical outcome. Arch. Pathol. Lab. Med., 115: 558-562, 1991.
24. Dei Tos, A. P., Doglioni, C., Piccinin, S., Maestro, R., Mentzel, T., Barbareschi, M., Boiocchi, M., and Fletcher, C. D. Molecular abnormalities of the p53 pathway in dedifferentiated liposarcoma. J. Pathol., 181: 8-13, 1997.
25. Unni, K. K., and Dahlin, D. C. Dahlin's Bone Tumors: General Aspects and Data on 11,087 Cases. Philadelphia: Lippincott-Raven, 1996.
26. Cordon-Cardo, C., Latres, E., Drobnjak, M., Oliva, M. R., Pollack, D., Woodruff, J. M., Marechal, V., Chen, J., Brennan, M. F., and Levine, A. J. Molecular abnormalities of mdm2 and p53 genes in adult soft tissue sarcomas. Cancer Res., 54: 794-799, 1994.
27. 1-S checkpoint in myxoid and round cell liposarcoma. Am. J. Pathol., 151: 1531-1539, 1997.
28. Rudolph, P., Kellner, U., Chassevent, A., Collin, F., Bonichon, F., Parwaresch, R., and Coindre, J. M. Prognostic relevance of a novel proliferation marker, Ki-S11, for soft-tissue sarcoma. A multivariate study. Am. J. Pathol., 150: 1997-2007, 1997.
29. Schmidt, R. A., Rusch, V. W., and Piantadosi, S. A flow cytometric study of non-small cell lung cancer classified as T1N0. Cancer (Phila.), 69: 78-85, 1992.
30. Kawai, A., Noguchi, M., Beppu, Y., Yokoyama, R., Mukai, K., Hirohashi, S., Inoue, H., and Fukuma, H. Nuclear immunoreaction of p53 protein in soft tissue sarcomas. A possible prognostic factor. Cancer (Phila.), 73: 2499-2505, 1994.
31. Latres, E., Drobnjak, M., Pollack, D., Oliva, M. R., Ramos, M., Karpeh, M., Woodruff, J. M., and Cordon-Cardo, C. Chromosome 17 abnormalities and TP53 mutations in adult soft tissue sarcomas. Am. J. Pathol., 145: 345-355, 1994.
32. Toffoli, G., Doglioni, C., Cernigoi, C., Frustaci, S., Perin, T., Canal, B., and Boiocchi, M. P53 overexpression in human soft tissue sarcomas: relation to biological aggressiveness. Ann. Oncol., 5: 167-172, 1994.
33. Yang, P., Hirose, T., Hasegawa, T., Seki, K., Sano, T., and Hizawa, K. Prognostic implication of the p53 protein and Ki-67 antigen immunohistochemistry in malignant fibrous histiocytoma. Cancer (Phila.), 76: 618-625, 1995.
34. Swanson, P. E. HIERanarchy: the state of the art in immunohistochemistry [editorial]. Am. J. Clin. Pathol., 107: 139-140, 1997.
35. Trojani, M., Contesso, G., Coindre, J. M., Rouesse, J., Bui, N. B., de Mascarel, A., Goussot, J. E., David, M., Bonichon, F., and Lagarde, C. Soft-tissue sarcomas of adults; study of pathological prognostic variables and definition of a histopathological grading system. Int. J. Cancer, 33: 37-42, 1984.
36. Nieweg, O. E., Pruim, J., van Ginkel, R. J., Hoekstra, H. J., Paans, A. M., Molenaar, W. M., Koops, H. S., and Vaalburg, W. Fluorine-18-fluorodeoxyglucose PET imaging of soft-tissue sarcoma. J. Nucl. Med., 37: 257-261, 1996.
37. Gerdes, J., Li, L., Schlueter, C., Duchrow, M., Wohlenberg, C., Gerlach, C., Stahmer, I., Kloth, S., Brandt, E., and Flad, H. D. Immunobiochemical and molecular biologic characterization of the cell proliferation-associated nuclear antigen that is defined by monoclonal antibody Ki-67. Am. J. Pathol., 138: 867-873, 1991.
38. Isola, J., Helin, H. and Kallioniemi, O. P. Immunoelectron-microscopic localization of a proliferation-associated antigen Ki-67 in MCF-7 cells. Histochem. J., 22: 498-506, 1990.
39. Levine, E. A., Holzmayer, T., Bacus, S., Mechetner, E., Mera, R., Bolliger, C., Roninson, I. B., and Das Gupta, T. K. Evaluation of newer prognostic markers for adult soft tissue sarcomas. J. Clin. Oncol., 15: 3249-3257, 1997.
40. Ueda, T., Aozasa, K., Tsujimoto, M., Ohsawa, M., Uchida, A., Aoki, Y., Ono, K., and Matsumoto, K. Prognostic significance of Ki-67 reactivity in soft tissue sarcomas. Cancer (Phila.), 63: 1607-1611, 1989.
41. Kroese, M. C., Rutgers, D. H., Wils, I. S., Van Unnik, J. A., and Roholl, P. J. The relevance of the DNA index and proliferation rate in the grading of benign and malignant soft tissue tumors. Cancer (Phila.), 65: 1782-1788, 1990.
42. Matsuno, T., Gebhardt, M. C., Schiller, A. L., Rosenberg, A. E., and Mankin, H. J. The use of flow cytometry as a diagnostic aid in the management of soft-tissue tumors. J. Bone Joint Surg. Am., 70: 751-759, 1988.
43. Swanson, S. A., and Brooks, J. J. Proliferation markers Ki-67 and p105 in soft-tissue lesions. Correlation with DNA flow cytometric characteristics. Am. J. Pathol., 137: 1491-1500, 1990.
44. Finlay, C. A., Hinds, P. W., Tan, T. H., Eliyahu, D., Oren, M., and Levine, A. J. Activating mutations for transformation by p53 produce a gene product that forms an hsc70-p53 complex with an altered half-life. Mol. Cell. Biol., 8: 531-539, 1988.
45. Kastan, M. B., Onyekwere, O., Sidransky, D., Vogelstein, B., and Craig, R. W. Participation of p53 protein in the cellular response to DNA damage. Cancer Res., 51: 6304-6311, 1991.
46. Lane, D. P. Cancer. p53, guardian of the genome (see comments). Nature (Lond.), 358: 15-16, 1992.
47. Pollock, R. E. Molecular determinants of soft tissue sarcoma proliferation. Semin. Surg. Oncol., 10: 315-322, 1994.
48. Castresana, J. S., Rubio, M. P., Gomez, L., Kreicbergs, A., Zetterberg, A., and Barrios, C. Detection of TP53 gene mutations in human sarcomas. Eur. J. Cancer, 5: 735-738, 1995.
49. Golouh, R., Bracko, M., and Novak, J. Predictive value of proliferation-related markers, p53, and DNA ploidy for survival in patients with soft tissue spindle-cell sarcomas. Mod. Pathol., 9: 919-924, 1996.
50. Xiao, Z. X., Chen, J., Levine, A. J., Modjtahedi, N., Xing, J., Sellers, W. R., and Livingston, D. M. Interaction between the retinoblastoma protein and the oncoprotein MDM2. Nature (Lond.), 375: 694-698, 1995.
51. Martin, K., Trouche, D., Hagemeier, C., Sorensen, T. S., La Thangue, N. B., and Kouzarides, T. Stimulation of E2F1/DP1 transcriptional activity by MDM2 oncoprotein. Nature (Lond.), 375: 691-694, 1995.
52. Leach, F. S., Tokino, T., Meltzer, P., Burrell, M., Oliner, J. D., Smith, S., Hill, D. E., Sidransky, D., Kinzler, K. W., and Vogelstein, B. p53 Mutation, and MDM2 amplification in human soft tissue sarcomas. Cancer Res., 53: 2231-2234, 1993.
53. Oliner, J. D., Kinzler, K. W., Meltzer, P. S., George, D. L., and Vogelstein, B. Amplification of a gene encoding a p53-associated protein in human sarcomas (see comments). Nature (Lond.), 358: 80-83, 1992.
54. Sherr, C. J. Cancer cell cycles. Science (Washington DC), 274: 1672-1677, 1996.
55. Enzinger, F. M., and Weiss, S. W. Soft Tissue Tumors. St. Louis: Mosby, 1995.